2,121
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Keratin 17 upregulation promotes cell metastasis and angiogenesis in colon adenocarcinoma

, , , , , , , , , & show all
Pages 12598-12611 | Received 10 Aug 2021, Accepted 17 Nov 2021, Published online: 22 Dec 2021

References

  • Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164.
  • Chesnokova V, Zonis S, Zhou C, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113(23):E3250–3259.
  • Chen MC, Chen KC, Chang GC, et al. RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer. Cell Death Dis. 2020;11(4):265.
  • Jacob JT, Coulombe PA, Kwan R, et al. Filaments. Cold Spring Harb Perspect Biol. 2018;10.
  • Govaere O, Komuta M, Berkers J, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014;63(4):674–685.
  • Weng YR, Cui Y, Fang JY. Biological functions of cytokeratin 18 in cancer. Mol Cancer Res. 2012;10(4):485–493.
  • Depianto D, Kerns ML, Dlugosz AA, et al. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010;42(10):910–914.
  • Chung BM, Arutyunov A, Ilagan E, et al. Regulation of C-X-C chemokine gene expression by keratin 17 and hnRNP K in skin tumor keratinocytes. J Cell Biol. 2015;208(5):613–627.
  • Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFα-dependent fashion. Genes Dev. 2006;20(10):1353–1364.
  • Hobbs RP, Batazzi AS, Han MC, et al. Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo. Oncogene. 2016;35(43):5653–5662.
  • Chen R, Fu M, Zhang G, et al. Rac1 regulates skin tumors by regulation of keratin 17 through recruitment and interaction with CD11b+Gr1+ cells. Oncotarget. 2014;5(12):4406–4417.
  • Babu S, Mockler DC, Roa-Pena L, et al. Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia. Mod Pathol. 2019;32(5):717–724.
  • Roa-Pena L, Leiton CV, Babu S, et al. Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer. Sci Rep. 2019;9(1):11239.
  • Ide M, Kato T, Ogata K, et al. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma. Ann Surg Oncol. 2012;19(11):3506–3514.
  • Kim CY, Jung WY, Lee HJ, et al. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma. Oncol Rep. 2012;27(3):608–620.
  • Ujiie D, Okayama H, Saito K, et al. KRT17 as a prognostic biomarker for stage II colorectal cancer. Carcinogenesis. 2020;41(5):591–599.
  • Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675–678.
  • Subauste MC, Kupriyanova TA, Conn EM, et al. Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems. Clin Exp Metastasis. 2009;26(8):1033–1047.
  • Liu LZ, Jing Y, Jiang LL, et al. Acacetin inhibits VEGF expression, tumor angiogenesis and growth through AKT/HIF-1alpha pathway. Biochem Biophys Res Commun. 2011;413(2):299–305.
  • Saur D, Seidler B, Schneider G, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology. 2005;129(4):1237–1250.
  • Zohdy M, Abd El Hafez A, Abd Allah MYY, et al. Ki67 and CD31 differential expression in cutaneous T-cell lymphoma and its mimickers: association with clinicopathological criteria and disease advancement. Clin Cosmet Investig Dermatol. 2020;13:431–442.
  • Nakanishi M, Montrose DC, Clark P, et al. Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis. Cancer Res. 2008;68(9):3251–3259.
  • Sass FA, Schmidt-Bleek K, Ellinghaus A, et al. CD31+ cells from peripheral blood facilitate bone regeneration in biologically impaired conditions through combined effects on immunomodulation and angiogenesis. J Bone Miner Res. 2017;32(5):902–912.
  • Bosmuller H, Pfefferle V, Bittar Z, et al. Microvessel density and angiogenesis in primary hepatic malignancies: differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Pathol Res Pract. 2018;214(8):1136–1141.
  • Fang JH, Zhou HC, Zeng C, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011;54(5):1729–1740.
  • Polakis P. Wnt signaling in cancer. Cold Spring Harb Perspect Biol. 2012;4(5):a008052–a008052.
  • Chocarro-Calvo A, Garcia-Martinez JM, Ardila-Gonzalez S, et al. Glucose-induced beta-catenin acetylation enhances Wnt signaling in cancer. Mol Cell. 2013;49:474–486.
  • Tenbaum SP, Ordonez-Moran P, Puig I, et al. Palmer, beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer. Nat Med. 2012;18(6):892–901.
  • Drost J, van Jaarsveld RH, Ponsioen B, et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature. 2015;521(7550):43–47.
  • Sievers S, Fritzsch C, Grzegorczyk M, et al. Absolute beta-catenin concentrations in Wnt pathway-stimulated and non-stimulated cells. Biomarkers. 2006;11(3):270–278.
  • Bae JA, Kho DH, Sun EG, et al. Elevated coexpression of KITENIN and the ErbB4 CYT-2 isoform promotes the transition from colon adenoma to carcinoma following APC loss. Clin Cancer Res. 2016;22(5):1284–1294.
  • Dow LE, O’Rourke KP, Simon J, et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell. 2015;161(7):1539–1552.